Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS

Clinical trial NCT04810182 · COMPLETED

Trial details

NCT number: NCT04810182
Sponsor: Istituto Oncologico Veneto IRCCS
Status: COMPLETED
Study type: OBSERVATIONAL

Glioblastoma Multiforme

Start date: 2020-09-10
Primary completion: 2023-12-31
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.